Evidence map›Paper›PMID 41304401›Full record

ArticlePolymers2025

Preparation and Paclitaxel-Loading of Regenerated Chitin Nanoparticles.

Yanping Li, Dan Qiu, Xuechen Zhuang, Zhiduo Pei, Tao Li, Shanggui Deng

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanping LiSchool of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Dan QiuSchool of Biological and Chemical Engineering, NingboTech University, Ningbo 315199, China.
Xuechen ZhuangSchool of Materials and Chemical Engineering, Ningbo University of Technology, Ningbo 315211, China.
Zhiduo PeiSchool of Biological and Chemical Engineering, NingboTech University, Ningbo 315199, China.
Tao LiSchool of Biological and Chemical Engineering, NingboTech University, Ningbo 315199, China.
Shanggui DengSchool of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.

Funding

Chinese College Stu-dents' Innovation and Entrepreneurship Training Program 202513022052Key R & D Program Project of Ningbo City 2025Z112Specialty Fund of Zhejiang Institute Tianjin University ZITJU2024-ZYHT004Zhejiang Province's Special Support Program 2023R5232Zhejiang Provincial Natural Science Foundation of China LMS25B060006
6 · The paper itself

Abstract

This study aims to investigate biodegradable and biocompatible chitin as a natural carrier for loading the hydrophobic anti-cancer drug paclitaxel (PTX) for the first time, resulting in a new loading system of chitin nanoparticles-paclitaxel (ChNps-PTX). The well-dispersed chitin nanoparticles (ChNps) and ChNps-PTX were prepared via a water-dripping regeneration method. The functional groups, crystal form, and the high degree of acetylation (DA = 96.03%) of ChNps did not change during regeneration, suggesting that ChNps retained the complete molecular structure of chitin. The average particle size of ChNps-PTX was approximately 93.11 nm, which was larger than that of ChNps (84.06 nm) because of loading PTX (the drug loading was approximately 8.01%). TEM and CLSM were employed to confirm PTX existence in ChNps-PTX, and the nano-strip PTX (30.52 ± 6.78 nm in length and 16.02 ± 2.77 nm in width) was found for the first time. Loading of PTX resulted in ChNps-PTX presenting a new characteristic peak at 1734 cm

Indexed as

chitinchitin nanoparticles (ChNps)chitin nanoparticles-paclitaxel (ChNps–PTX)crystallinitynano-strip PTXregeneration

Identifiers

PMID41304401
PMCPMC12656392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.